H.C. Wainwright raised the firm’s price target on Viridian Therapeutics (VRDN) to $34 from $27 and keeps a Buy rating on the shares. The ...

Topline data from Phase 2b/3 trial of izokibep as a treatment for non-infectious non-anterior uveitis expected in December 2024 Positive lonigutamab EOP2 FDA interaction completed and initiation of ...

Ocular autoimmune disease involves the immune system attacking the tissues of the eye. These diseases typically manifest through an autoantibody response targeting the retina, uvea, vitreous, and ...

Ever since I became a contact lens wearer many years ago, chronic dry eyes and I have become fast and familiar friends. That ...

A doctor who was watching Nicole McGuiness on Beachfront Bargain Hunt contacted the house hunter after seeing an abnormal ...

In June 2024, a canalicular gel device (Lacrifill, Nordic Pharma) was introduced to the US market, and a recent study has ...

Researchers successfully tested the safety and preliminary efficacy of stem-cell-derived corneal implants, showing promise ...

sativus) plant, contains compounds that researchers have explored to help treat depression, anxiety, eye issues, and more ...

A new treatment that could prevent blindness in children with the CLN2 type Batten disease has been trialed by clinicians and ...

These are the best vitamins and supplements for eye health, which are great for supporting your vision and helping you take ...

The solution has secured coverage across all US Medicaid programs and 60% of commercial insurance providers, enhancing access ...